Research areas
Dr Muge Cevik is a clinical lecturer in infectious diseases and medical virology. Her research interests focus on HIV, tuberculosis, other tropical infections and emerging infections including Covid-19 since the beginning of 2020.
During the Covid-19 pandemic, as well as working on the NHS front line of the response, Dr Cevik provided scientific advice to the Chief Medical Officer – Scotland and advisory groups on recent scientific developments on Covid-19. She has been co-opted to NERVTAG (New and Emerging Respiratory Virus Threats Advisory Group) as a member for Covid-19, advising and producing guidance documents for UK-SAGE (Scientific Advisory Group for Emergencies). She also provided advice and consultancy to the World Health Organisation (WHO) on risk communication during Covid-19 pandemic.
Dr Cevik is also coordinating the recruitment of hospitalised COVID-19 patients in South East Asia and South Africa working closely with the International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) funded by the Wellcome Trust. Additionally, she is co-leading a household transmission study in Scotland as well as a prospective study to quantify the burden of Covid-19 in patients with tuberculosis in Kampala, Uganda, with support from GCRF-NIHR. She is part of the CORRE Network (Covid-19 International Rapid Evidence Reviews Group) working towards providing rapid reviews for governments and the WHO.
Alongside her academic work, Dr Cevik developed a strong interest in science communication. She is passionate about the value of integrating science communication into our efforts to disseminate research, which has the potential to enhance knowledge exchange among scientists and physicians, and the broader public.
Selected publications
-
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs
Cevik, M., Sturdy, A., Maraolo, A. E., Dekkers, B. G. J., Akkerman, O. W. & Gillespie, S. H., 1 Sept 2024, In: International Journal of Tuberculosis and Lung Disease. 28, 9, p. 454-460 7 p.Research output: Contribution to journal › Article › peer-review
-
Open access
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial
Cevik, M., Thompson, L. C., Upton, C., Rolla, V. C., Malahleha, M., Mmbaga, B., Ngubane, N., Abu Bakar, Z., Rassool, M., Variava, E., Dawson, R., Staples, S., Lalloo, U., Louw, C., Conradie, F., Eristavi, M., Samoilova, A., Skornyakov, S. N., Ntinginya, N. E. & Haraka, F. & 28 others, , 1 Sept 2024, In: The Lancet Infectious Diseases. 24, 9, p. 1003-1014 12 p.Research output: Contribution to journal › Article › peer-review
-
Open access
Clinical course and management of COVID-19 in the era of widespread population immunity
Meyerowitz, E. A., Scott, J., Richterman, A., Male, V. & Cevik, M., Feb 2024, In: Nature Reviews Microbiology. 22, p. 75-88Research output: Contribution to journal › Review article › peer-review
-
Gender and geographical representation at infectious diseases and clinical microbiology conferences
Last, K., Hübsch, L., Marcelin, J. R., Huttner, A., Cevik, M. & Papan, C., Mar 2024, In: Lancet Infectious Diseases. 24, 3, p. e153-e154 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Predictable excess hepatotoxicity in the SimpliciTB trial - Authors' reply
Cevik, M., Beumont, M., Sun, E., Sloan, D. J. & Gillespie, S. H., 28 Oct 2024, (E-pub ahead of print) In: Lancet Infectious Diseases.Research output: Contribution to journal › Article
-
Open access
The 2023 – 2024 multi-source mpox outbreaks of Clade I MPXV in sub-Saharan Africa: alarm bell for Africa and the World
Cevik, M., Tomori, O., Mbala, P., Scagliarini, A., Petersen, E., Low, N., Heymann, D., Shan Lee, S. & Blumberg, L., 1 Sept 2024, In: IJID Regions. 12, 3 p., 100397.Research output: Contribution to journal › Editorial › peer-review
-
Open access
Emergence of mpox in the post-smallpox era - a narrative review on mpox epidemiology
Van Dijck, C., Hoff, N. A., Mbala-Kingebeni, P., Low, N., Cevik, M., Rimoin, A. W., Kindrachuk, J. & Liesenborghs, L., 1 Dec 2023, In: Clinical Microbiology and Infection. 29, 12, p. 1487-1492 6 p.Research output: Contribution to journal › Review article › peer-review
-
Estimating the global impact of coronavirus disease 2019 on people living with HIV
Thornhill, J., Orkin, C. & Cevik, M., 1 Feb 2023, In: Current Opinion in Infectious Diseases. 36, 1, p. 20-25 6 p.Research output: Contribution to journal › Review article › peer-review
-
Open access
In-person schooling is essential even during periods of high transmission of COVID-19
Munro, A., Buonsenso, D., González-Dambrauskas, S., Hughes, R. C., Bhopal, S. S., Vásquez-Hoyos, P., Cevik, M., Rubio, M. L. M. & Roland, D., 1 Jun 2023, In: BMJ Evidence-Based Medicine. 28, 3, p. 175-179 5 p.Research output: Contribution to journal › Article › peer-review
-
Open access
Mpox virus and transmission through sexual contact: defining the research agenda
Low, N., Bachmann, L. H., Ogoina, D., McDonald, R., Ipekci, A. M., Quilter, L. A. S. & Cevik, M., 17 Jan 2023, (E-pub ahead of print) In: PLoS Medicine. 20, 1, 8 p., e1004163.Research output: Contribution to journal › Comment/debate